| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 221.107 | 85 |
| GSM780708 | Untreated after 4 days (C2_1) | 246.626 | 86 |
| GSM780709 | Untreated after 4 days (C3_1) | 253.588 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 212.956 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 212.191 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 262.598 | 86 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 236.214 | 85 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 251.832 | 86 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 192.728 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 250.479 | 86 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 243.277 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 185.618 | 83 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 237.384 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 235.548 | 85 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 266.679 | 86 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 201.457 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 239.389 | 85 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 255.532 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 242.004 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 206.898 | 84 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 225.057 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 204.094 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 216.311 | 84 |